The arrival of BrightMeds GLP-1 marks a vital shift in how healthcare providers manage type 2 diabetes . This novel medication category offers a unique way of working that also reduces glucose but can facilitate weight loss and improve cardiovascular outcomes. Early results suggest this therapy i